Leading domestic manufacturer strengthens global distribution network to meet rising international demand for high purity pharmaceutical excipients.

GUANGZHOU, CHINA – 2026 – Guangzhou Hanfang Pharmaceutical Company Limited today officially announces the expansion of its export grade egg yolk lecithin production capacity. This strategic initiative directly addresses critical supply chain bottlenecks faced by global pharmaceutical and biotech manufacturers. The upgraded output features enhanced purity standards, optimized extraction processes, and streamlined international logistics. Through this operational enhancement, the company aims to secure reliable sourcing for overseas clients while reinforcing its position in the international lipid raw material market. Standard bulk orders are now available through authorized distributors worldwide.

Core Technical Breakthroughs and Product Highlights

The newly scaled production line leverages proprietary green technology integration to deliver superior pharmaceutical grade materials. By implementing supercritical carbon dioxide extraction combined with membrane separation and chromatographic purification, the facility eliminates traditional solvent residues while maximizing active phospholipid retention. This method ensures consistent particle size distribution and exceptional emulsification stability, which are critical parameters for advanced drug delivery systems and injectable formulations. The technical upgrade successfully increases domestic substitution rates for high end lipid excipients, significantly reducing reliance on imported alternatives. The Hanfang brand portfolio continues to demonstrate measurable performance advantages in clinical compounding environments.

Global Compliance and Certifications

To satisfy stringent international regulatory requirements, the expanded export grade egg yolk lecithin portfolio fully complies with European Pharmacopoeia and United States Pharmacopeia standards. The product has secured European CEP certification and maintains active FDA US DMF filings, facilitating faster approval pathways for downstream manufacturers in North America and Europe. Additional regulatory registrations cover Mexican Cofepris and Indian DCGI frameworks, ensuring seamless market access across diverse geographic regions. All batches undergo rigorous quality control protocols aligned with Good Manufacturing Practice guidelines. Independent laboratory verification confirms heavy metal limits and microbial counts consistently fall below maximum permitted thresholds.

Supply Information and Customization Services

Bulk procurement channels are now open for international partners seeking reliable long term supply agreements. The company offers flexible packaging configurations, including sterile multi layer laminated bags and moisture resistant industrial containers tailored for cross border shipping. Dedicated technical support teams provide formulation consultation and application testing to assist clients in optimizing dosage forms. Custom specification adjustments are available upon request, accommodating unique viscosity thresholds and phosphatidylcholine concentration requirements. Logistics coordination covers air freight, sea freight, and bonded warehouse storage to minimize transit delays.

Management Statements

The launch of our upgraded export grade egg yolk lecithin represents a decisive milestone in our global commercialization roadmap. A senior executive at Guangzhou Hanfang Pharmaceutical Company Limited emphasized that sustained investment in advanced lipid processing infrastructure directly supports international pharmaceutical innovation cycles. The organization remains dedicated to delivering clinically validated raw materials that meet the most demanding regulatory benchmarks. Strategic partnerships with global research institutions will further accelerate technology transfer and application validation.

Industry Context and Strategic Alignment

Recent market analyses indicate steady growth in global demand for high purity pharmaceutical excipients driven by increased adoption of complex injectable therapies and targeted drug delivery platforms. As a nationally recognized specialized and sophisticated enterprise, the organization plays a vital role in stabilizing domestic supply chains for critical medicinal ingredients. Expanding export capabilities aligns with broader industry objectives to enhance material security and reduce geopolitical supply vulnerabilities. Regulatory harmonization efforts across major trading blocs continue to elevate baseline quality expectations for lipid based carriers.

Future Development Roadmap

Looking ahead, the enterprise will continue prioritizing research and development investments in next generation lipid technologies and sustainable manufacturing practices. Upcoming initiatives include scaling additional green extraction facilities and strengthening regional distribution hubs to shorten lead times for key markets. Continuous improvement of quality management systems will further solidify operational excellence across all production stages. The company plans to integrate digital traceability modules into existing ERP workflows to enhance transparency for international auditors.

About the Enterprise

Guangzhou Hanfang Pharmaceutical Company Limited was established in nineteen ninety eight and operates as a core modern pharmaceutical enterprise under a leading state owned group. Headquartered in Guangzhou, the organization specializes in pharmaceutical raw materials, medicinal lipid excipients, and advanced health products. Backed by a national engineering research center and multiple provincial laboratories, the company has successfully developed domestically produced injectable lipid formulations that replace traditional imports. Products are distributed across more than thirty countries and regions, serving thousands of pharmaceutical and healthcare partners worldwide. The corporate mission centers on advancing scientific independence and safeguarding global health through innovative pharmaceutical solutions.

Common Questions

Q: What distinguishes this export grade egg yolk lecithin from conventional suppliers?
A: It utilizes patented supercritical extraction technology, holds dual EU CEP and FDA US DMF certifications, and guarantees batch consistency for clinical applications.

Q: How does the company ensure traceability for international shipments?
A: Every production lot follows strict GMP documentation protocols, includes comprehensive analytical certificates, and maintains full supply chain visibility from raw material sourcing to final delivery.

Contact Us

Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/
Headquarters Address: No. 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou
Production Base Address: No. 8 Wenquan Avenue, Conghua District, Guangzhou

Copyright © 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.